Extreme Heat Dome Threatens July 4 Celebrations, Power Grids
A dangerous heat dome is directly threatening the safety of tens of millions of Americans celebrating the nation's 250th birthday this weekend, straining power grids, forcing event delays at the National Mall, and posing life-threatening health risks. Highly actionable for readers.

The Morning Brief · July 3, 2026 · Based on reporting by CNBC Top News
An extreme heat dome is bearing down on the U.S. for the July 4 weekend, delaying celebrations for the nation's 250th birthday and threatening to overwhelm power grids. Freedom 250 organizers said Thursday that entry to the National Mall has been delayed for a record-breaking fireworks show. Washington, D.C., is bracing for extreme heat.
The heat could also disrupt one of the busiest travel weeks of the year, potentially forcing some Americans to change their plans. Beyond travel headaches, the heat wave puts millions at risk of heat-related illness over the holiday. Experts recommend basic precautions to avoid heat illness during the weekend's festivities.
Sources
CNBC Top News — Extreme heat wave threatens U.S. power grids and July 4 travel
The heat wave threatens to overwhelm U.S. grids and may force some to change their plans on one of the busiest travel weeks of the year.
The Hill — Extreme heat advisory delays National Mall July 4 event, organizers say
Entry to the National Mall for a record-breaking fireworks show celebrating July 4 has been delayed as Washington, D.C. braces for extreme heat, Freedom 250 organizers said Thursday.
Scientific American — How to avoid heat illness and stay safe during the mega heat wave
A heat wave over the Fourth of July weekend could put millions at risk of heat-related illnesses. Here's what to do to stay safe.
Science & TechnologyScientists Find How Tau Proteins Spread in Alzheimer's
Science Daily
Science & TechnologyTrump Administration Vets Access to Most Powerful AI Models
AP News
Science & TechnologyIBM Builds Sub-1 Nanometer Chip With 100 Billion Transistors
Ars Technica
Science & TechnologyFDA Panel Unanimously Backs Moderna mRNA Flu Vaccine
Ars Technica